Neil Exter joined Third Rock Ventures in 2007 and plays an integral role in the overall formation, development and business strategy of its portfolio companies. Mr. Exter has more than 17 years of business development and strategic experience, facilitating the successful development and implementation of operations and collaborations across the spectrum of newly emerging and established biotech companies. Prior to joining Third Rock Ventures, Mr. Exter was the chief business officer of Alantos Pharmaceuticals, leading the sale of the company to Amgen, and vice president of Millennium Pharmaceuticals, directing in-licensing and M&A. Earlier in his career, he held various executive management roles within the high technology industry, including tenures at Hewlett Packard and Wang Laboratories. Mr. Exter is a member of the board of overseers and the board research committee at Children’s Hospital Boston. Additionally, he is a member of the Innovation Research Fund at Partners Healthcare and the advisory council of the Electrical and Computer Engineering Department at Cornell. Mr. Exter received his B.S. from Cornell University, M.S. from Stanford University and M.B.A. as a Baker Scholar from Harvard Business School.